Sodium Tetradecyl Sulfate

Injection, 3%

Therapeutic Category: Sclerosing Agent

  • FDA-Approved
  • AP Rated
  • Does Not Contain Rubber Latex
  • Bar Coded

A regulated and approved generic Sodium Tetradecyl Sulfate, 3% is now available. Remember, “if an FDA-approved drug is commercially available, the use of an unapproved compounded drug confers additional risk with no commensurate benefit.” [1]

PACKAGE INSERT
SDS

Compounded Drugs May Elevate Risk

Lack of sterility, microbial outbreaks, and negative patient outcomes. These are the documented problems that have occurred with compounding pharmacy products. Lacking FDA oversight, these pharmacies answer only to state authorities.
Sodium tetradecyl sulfate has a history with compounded pharmacies as well: “[Researchers] investigated content variability of compounded sodium tetradecyl sulfate solutions and found that compounding pharmacies were using a lower-quality ingredient as a starting material, which produced significant concentrations of a highly toxic contaminant called carbitol.” [2]

Healthcare Facilities May Be Liable

A string of “tainted drug” lawsuits have targeted hospitals and HCPs for using drugs created by compounding pharmacies. According to Michael E. Clark, vice-chair of the American Bar Association’s Health Law Section, “Doctors seriously should consider the costs and benefits of using a compounding facility and be sure the risks are worth it. The fact that compounding centers are not regulated by the Food and Drug Administration makes them less legally secure than alternatives.”
Protect your patients and your facility by using FDA-approved generics when they are available.
[1] Gudeman J, Jozwiakowski M, Chollet J, Randell M. Potential risks of pharmacy compounding. Drugs R D. 2013;13(1):1–8. doi:10.1007/s40268-013-0005-9
[2]Goldman, M. P. (2004), Sodium Tetradecyl Sulfate for Sclerotherapy Treatment of Veins: Is Compounding Pharmacy Solution Safe?. Dermatologic Surgery, 30: 1454-1456. doi:10.1111/j.1524-4725.2004.30502.x

Sodium Tetradecyl Sulfate

Injection, 3%

Therapeutic Category: Sclerosing Agent

  • FDA-Approved
  • AP Rated
  • Does Not Contain Rubber Latex
  • Bar Coded

A regulated and approved generic Sodium Tetradecyl Sulfate, 3% is now available. Remember, “if an FDA-approved drug is commercially available, the use of an unapproved compounded drug confers additional risk with no commensurate benefit.” [1]

PACKAGE INSERT
SDS

Compounded Drugs May Elevate Risk

Lack of sterility, microbial outbreaks, and negative patient outcomes–these are the documented problems that have occurred with compounding pharmacy products. Lacking FDA oversight, these pharmacies answer only to state authorities.

Sodium tetradecyl sulfate has a history with compounded pharmacies as well: “[Researchers] investigated content variability of compounded sodium tetradecyl sulfate solutions and found that compounding pharmacies were using a lower-quality ingredient as a starting material, which produced significant concentrations of a highly toxic contaminant called carbitol.” [2]

 

Healthcare Facilities May Be Liable

 
A number of “tainted drug” lawsuits have targeted hospitals and HCPs for using drugs created by compounding pharmacies. According to Michael E. Clark, vice-chair of the American Bar Association’s Health Law Section, “Doctors seriously should consider the costs and benefits of using a compounding facility and be sure the risks are worth it. The fact that compounding centers are not regulated by the Food & Drug Administration makes them less legally secure than alternatives.”
 
Protect your patients and your facility by using FDA-approved generics when they are available.
 
[1] Gudeman J, Jozwiakowski M, Chollet J, Randell M. Potential risks of pharmacy compounding. Drugs R D. 2013;13(1):1–8. doi:10.1007/s40268-013-0005-9.
[2]Goldman, M. P. (2004), Sodium tetradecyl sulfate for sclerotherapy treatment of veins: is compounding pharmacy solution safe? Dermatol Surg. 2004 (12 pt 1): 1454-1456. doi:10.1111/j.1524-4725.2004.30502.x.
 
 

Sodium Tetradecyl Sulfate

Injection, 3%

Therapeutic Category: Sclerosing Agent

  • FDA-Approved
  • AP Rated
  • Does Not Contain Rubber Latex
  • Bar Coded

A regulated and approved generic Sodium Tetradecyl Sulfate, 3% is now available. Remember, “if an FDA-approved drug is commercially available, the use of an unapproved compounded drug confers additional risk with no commensurate benefit.” [1]

PACKAGE INSERT
SDS

Compounded Drugs May Elevate Risk

Lack of sterility, microbial outbreaks, and negative patient outcomes. These are the documented problems that have occurred with compounding pharmacy products. Lacking FDA oversight, these pharmacies answer only to state authorities.
Sodium tetradecyl sulfate has a history with compounded pharmacies as well: “[Researchers] investigated content variability of compounded sodium tetradecyl sulfate solutions and found that compounding pharmacies were using a lower-quality ingredient as a starting material, which produced significant concentrations of a highly toxic contaminant called carbitol.” [2]

Healthcare Facilities May Be Liable

A string of “tainted drug” lawsuits have targeted hospitals and HCPs for using drugs created by compounding pharmacies. According to Michael E. Clark, vice-chair of the American Bar Association’s Health Law Section, “Doctors seriously should consider the costs and benefits of using a compounding facility and be sure the risks are worth it. The fact that compounding centers are not regulated by the Food and Drug Administration makes them less legally secure than alternatives.”
Protect your patients and your facility by using FDA-approved generics when they are available.
[1] Gudeman J, Jozwiakowski M, Chollet J, Randell M. Potential risks of pharmacy compounding. Drugs R D. 2013;13(1):1–8. doi:10.1007/s40268-013-0005-9
[2]Goldman, M. P. (2004), Sodium Tetradecyl Sulfate for Sclerotherapy Treatment of Veins: Is Compounding Pharmacy Solution Safe?. Dermatologic Surgery, 30: 1454-1456. doi:10.1111/j.1524-4725.2004.30502.x

Product Information

NDCStrengthConcentrationFill VolumeContainer SizeClosureUnit of Sale
24201-201-0560 mg/2 mL30 mg/mL2 mL2 mL Vial13 mm5

Wholesaler Item Numbers

AmerisourceBergenCardinal HealthFFFHenry ScheinMcKesson PharmaMcKesson Med-SurgMorris & Dickson
102322355586151SOD020105137443534798391155343826214

To order Leucadia products, please contact your wholesaler or contact customer service via email.

Call our customer service at 844-538-2231.